SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14963/141351_B_8_3_rna_selected_60x60.jpg) | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30179/63731_B_9_2_rna_selected_60x60.jpg) | Group enriched |
SLC7A9 | Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/42591/ihc_cell_selected_60x60.jpg) | ![](/images/42591/106689_B_7_7_rna_selected_60x60.jpg) | Group enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/2426/ihc_cell_selected_60x60.jpg) | ![](/images/2426/6196_B_7_3_rna_selected_60x60.jpg) | Group enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58564/130831_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CDHR2 | Cadherin-related family member 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/17053/ihc_cell_selected_60x60.jpg) | ![](/images/17053/38962_B_8_5_rna_selected_60x60.jpg) | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21939/147487_B_6_5_rna_selected_60x60.jpg) | Group enriched |
DGAT1 | Diacylglycerol O-acyltransferase 1 | Enzymes Predicted membrane proteins
| | ![](/images/32853/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/32853/73788_B_9_4_rna_selected_60x60.jpg) | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28275/60871_B_9_1_rna_selected_60x60.jpg) | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3564/11400_B_8_2_rna_selected_60x60.jpg) | Group enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/32/1899_B_2_7_rna_selected_60x60.jpg) | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/45163/ihc_cell_selected_60x60.jpg) | ![](/images/45163/100518_B_9_1_rna_selected_60x60.jpg) | Group enriched |
MUC2 | Mucin 2, oligomeric mucus/gel-forming | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/6197/ihc_cell_selected_60x60.jpg) | ![](/images/5317/18074_B_8_1_rna_selected_60x60.jpg) | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | ![](/images/51162/ihc_cell_selected_60x60.jpg) | ![](/images/51162/124857_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/36493/78436_B_9_2_rna_selected_60x60.jpg) | Group enriched |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted secreted proteins
| | ![](/images/7286/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7286/23641_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SULT1B1 | Sulfotransferase family, cytosolic, 1B, member 1 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2107/142116_B_9_3_rna_selected_60x60.jpg) | Group enriched |
TMEM253 | Transmembrane protein 253 | Predicted membrane proteins
| | ![](/images/52329/if_selected_60x60.jpg) | ![](/images/52329/ihc_cell_selected_60x60.jpg) | ![](/images/52329/116988_B_8_5_rna_selected_60x60.jpg) | Group enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/36175/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36174/98822_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2417/6119_B_9_2_rna_selected_60x60.jpg) | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | ![](/images/2221/5839_B_9_3_rna_selected_60x60.jpg) | Group enriched |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes
| | ![](/images/44131/if_selected_60x60.jpg) | ![](/images/44131/ihc_cell_selected_60x60.jpg) | ![](/images/44131/97426_B_2_6_rna_selected_60x60.jpg) | Group enriched |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5128/14084_A_7_2_rna_selected_60x60.jpg) | Group enriched |
ITLN2 | Intelectin 2 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/6683/ihc_cell_selected_60x60.jpg) | ![](/images/6683/20105_B_9_2_rna_selected_60x60.jpg) | Group enriched |
MGAM | Maltase-glucoamylase (alpha-glucosidase) | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2270/8419_B_8_5_rna_selected_60x60.jpg) | Group enriched |
MUC17 | Mucin 17, cell surface associated | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31634/72330_B_8_2_rna_selected_60x60.jpg) | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | ![](/images/12012/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12012/28147_B_9_8_rna_selected_60x60.jpg) | Group enriched |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | ![](/images/9257/141347_B_8_4_rna_selected_60x60.jpg) | Group enriched |
REG4 | Regenerating islet-derived family, member 4 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25867/57482_B_2_4_rna_selected_60x60.jpg) | Group enriched |
SST | Somatostatin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/19472/ihc_cell_selected_60x60.jpg) | ![](/images/75/201_B_2_1_rna_selected_60x60.jpg) | Group enriched |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51051/113946_B_8_4_rna_selected_60x60.jpg) | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13690/31410_B_8_6_rna_selected_60x60.jpg) | Group enriched |